Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN pro...

Two brothers were forced to carry their deceased 17-year-old sister through flooded fields after being unable to find a vehicle due to road...

Tomatoes have been turned into purple by researchers and they have claimed that the nutritional value has gone up, Fox Weather reported quo...

According to doctors, the number of such cases has nearly doubled owing to an increased awareness about such infections necessitated by the...

According to the study, quinolone-resistant strains accounted for more than 85% of S Typhi (the bacteria that causes Typhoid fever) in Bang...

Temporary isolation then was the solution – first for 30 days imposed by Ragusa (now Dubrovnik) and then 40 days, or quarantena, by Venice....

In 2018, 2,439 people died because of four major water-borne diseases — cholera, acute diarrhoeal diseases (ADD), typhoid and viral hepatit...

This enables the procurement and supplies of this vaccine to UNICEF, Pan-American Health Organisation (PAHO) and GAVI-supported countries, ...

Hyderabad, Jan 3 (IANS) Bharat Biotech's Typhoid Conjugate Vaccine (TCV) against typhoid fever has received pre-qualification from the Worl...

Doctors say that while earlier oral drugs could cure most patients, they now need to give injectable antibiotics to 20-30% of the patients ...

Some of the most common ones include viral fever, the common cold, malaria, typhoid, hepatitis A, leptospirosis, diarrhoea and chikungunya.

The findings establish for the first time the causal link between bacterial infection and gallbladder cancer.

An antibiotic-resistant strain of typhoid bacterium is spreading globally and posing a public health threat, especially in developing count...

With 4,450 deaths reported yet, the current outbreak in west Africa is the largest and Ebola outbreak since the virus was first discovered ...

Under the licence, Novartis Vaccines Institute for Global Health (NVGH) will transfer technology to Hyderabad-based BioE.

The typhoid vaccine (Vi-CRM197) has achieved 'Proof of Concept' and has successful Phase 2 results. It will be transferred to BioE, Novarti...

Vaccine manufacturer Bharat Biotech and The University of Maryland Center for Vaccine Development (CVD) have received $ 4 million from The ...